Chemo Response Foretold by Leukemia Stem Cell Biomarker
December 8, 2016
No Comments
Princess Margaret Cancer Centre in Toronto is utilizing LSC17, a biomarker found in Leukemia Stem Cells, to determine if conventional treatments will be effective. If present, the biomarker causes greater chance of relapse. LSC17 causes